We hold our Annual General Meetings during our Annual Congress. If you were unable to attend, please see below for the AGM invitations, presentations, and minutes, and any election results for that year. This year the AGM will be organised at La Nuvola, Rome on 24 October 2024 @ 13.30. Our bylaws (articles of association) can be viewed here. The current ESGCT Board can be viewed here.
Please click here for 2015 AGM. Please click here for 2016 AGM. Please click here for 2017 AGM. Please click here for 2018 AGM. Please click here for 2019 AGM. Please click here for 2020 AGM Please click here for 2021 AGM Please click here for 2022 AGM Please click here for 2023 AGM Please click here for 2024 AGM
Non-viral genetic therapy strategies for the treatment of ataxia telangiectasia
James Grey received the ESGCT-sponsored prize for best poster presentation at the British Society for Gene and Cell Therapy (BSGCT) Annual Conference, which took place from 19-21 June 2019. Read about his winning presentation here!
Gene therapy for thrombotic thrombocytopaenic purpura
Robyn Bell received the ESGCT-sponsored prize for best oral presentation at the British Society for Gene and Cell Therapy (BSGCT) Annual Conference, which took place from 19-21 June 2019. Read about her winning presentation here!
CRISPR-Cas9 genome editing - molecular scissors a bit too sharp?
Grégoire Cullot received the ESGCT-sponsored prize for best oral presentation at the Société Française de Thérapie Cellulaire et Génique (SFTCG) Thematic Day on Viral Vectors, which took place on 17 May 2019 in Paris. Read about his winning presentation here!
Dgkk as a new therapeutic target in the Fmr1-KO murine model of Fragile X
Karima Habbas received the ESGCT-sponsored prize for best poster at the Société Française de Thérapie Cellulaire et Génique (SFTCG) Thematic Day on Viral Vectors, which took place on 17 May 2019 in Paris. Read about her winning presentation here!